These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9664948)

  • 1. Tacrolimus and cyclosporine efficacy in high-risk kidney transplantation. European Multicentre Tacrolimus (FK506) Renal Study Group.
    Hauser IA; Neumayer HN
    Transpl Int; 1998; 11 Suppl 1():S73-7. PubMed ID: 9664948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group.
    Wiesner RH
    Transplantation; 1998 Aug; 66(4):493-9. PubMed ID: 9734494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.
    Pirsch JD; Miller J; Deierhoi MH; Vincenti F; Filo RS
    Transplantation; 1997 Apr; 63(7):977-83. PubMed ID: 9112351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center.
    Kim HC; Hwang EA; Han SY; Park SB; Kim HT; Cho WH
    Transplant Proc; 2004 Sep; 36(7):2082-3. PubMed ID: 15518753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group.
    Neylan JF
    Transplantation; 1998 Feb; 65(4):515-23. PubMed ID: 9500626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group.
    Mayer AD; Dmitrewski J; Squifflet JP; Besse T; Grabensee B; Klein B; Eigler FW; Heemann U; Pichlmayr R; Behrend M; Vanrenterghem Y; Donck J; van Hooff J; Christiaans M; Morales JM; Andres A; Johnson RW; Short C; Buchholz B; Rehmert N; Land W; Schleibner S; Forsythe JL; Talbot D; Pohanka E
    Transplantation; 1997 Aug; 64(3):436-43. PubMed ID: 9275110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group.
    Miller J; Mendez R; Pirsch JD; Jensik SC
    Transplantation; 2000 Mar; 69(5):875-80. PubMed ID: 10755543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion.
    Filler G; Webb NJ; Milford DV; Watson AR; Gellermann J; Tyden G; Grenda R; Vondrak K; Hughes D; Offner G; Griebel M; Brekke IB; McGraw M; Balzar E; Friman S; Trompeter R
    Pediatr Transplant; 2005 Aug; 9(4):498-503. PubMed ID: 16048603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine and tacrolimus (FK506): a comparison of efficacy and safety profiles.
    Henry ML
    Clin Transplant; 1999 Jun; 13(3):209-20. PubMed ID: 10383101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
    Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y
    Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience.
    Neuhaus P; Blumhardt G; Bechstein WO; Platz KP; Jonas S; Mueller AR; Langrehr JM; Lohmann R; Schattenfroh N; Knoop M
    Transplantation; 1995 Jan; 59(1):31-40. PubMed ID: 7530868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: 1-year results of a large multicenter trial.
    Bechstein WO; Malaise J; Saudek F; Land W; Fernandez-Cruz L; Margreiter R; Nakache R; Secchi A; Vanrenterghem Y; Tydén G; Van Ophem D; Berney T; Boucek P; Landgraf R; Kahl A; Squifflet JP;
    Transplantation; 2004 Apr; 77(8):1221-8. PubMed ID: 15114089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective randomized trial comparing the efficacy of tacrolimus versus cyclosporine in black recipients of primary cadaveric renal transplants.
    Raofi V; Holman DM; Coady N; Vazquez E; Dunn TB; Bartholomew AM; Pollak R; Benedetti E
    Am J Surg; 1999 Apr; 177(4):299-302. PubMed ID: 10326847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European randomised trial of dual versus triple tacrolimus-based regimens for control of acute rejection in renal allograft recipients.
    Chang RW; Snowden S; Palmer A; Kwan JT; Nicholson M; Kashi SH; Fernando ON; Perner F; Neild GH
    Transpl Int; 2001 Dec; 14(6):384-90. PubMed ID: 11793035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term graft function with tacrolimus and cyclosporine in renal transplantation: paired kidney analysis.
    Cheung CY; Chan HW; Liu YL; Chau KF; Li CS
    Nephrology (Carlton); 2009 Dec; 14(8):758-63. PubMed ID: 20025685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A large, multicentre trial to compare the efficacy and safety of tacrolimus with cyclosporine microemulsion following renal transplantation.
    Sperschneider H;
    Transplant Proc; 2001; 33(1-2):1279-81. PubMed ID: 11267291
    [No Abstract]   [Full Text] [Related]  

  • 19. Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation.
    Treede H; Glanville AR; Klepetko W; Aboyoun C; Vettorazzi E; Lama R; Bravo C; Knoop C; Aubert JD; Reichenspurner H;
    J Heart Lung Transplant; 2012 Aug; 31(8):797-804. PubMed ID: 22554673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction.
    Tsamandas AC; Pham SM; Seaberg EC; Pappo O; Kormos RL; Kawai A; Griffith BP; Zeevi A; Duquesnoy R; Fung JJ; Starzl TE; Demetris AJ
    J Heart Lung Transplant; 1997 Jul; 16(7):723-34. PubMed ID: 9257254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.